United Therapeutics (FRA:UTH) Days Sales Outstanding : 40.31 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is United Therapeutics Days Sales Outstanding?

United Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was €249 Mil. United Therapeutics's Revenue for the three months ended in Dec. 2023 was €564 Mil. Hence, United Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 40.31.

The historical rank and industry rank for United Therapeutics's Days Sales Outstanding or its related term are showing as below:

FRA:UTH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.54 Med: 41.04 Max: 54.12
Current: 36.54

During the past 13 years, United Therapeutics's highest Days Sales Outstanding was 54.12. The lowest was 36.54. And the median was 41.04.

FRA:UTH's Days Sales Outstanding is ranked better than
80.18% of 888 companies
in the Biotechnology industry
Industry Median: 72.105 vs FRA:UTH: 36.54

United Therapeutics's Days Sales Outstanding declined from Dec. 2022 (43.47) to Dec. 2023 (40.31).

United Therapeutics Days Sales Outstanding Historical Data

The historical data trend for United Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Days Sales Outstanding Chart

United Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

40.69

39.76

37.34

38.33

39.66

United Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															43.47	32.16	31.27	39.47	40.31

Competitive Comparison of United Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, United Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, United Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where United Therapeutics's Days Sales Outstanding falls into.

United Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

United Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (208.058	+	255.751)	/	2 )	/	2134.317	*	365
=	231.9045					/	2134.317	*	365
=	39.66

United Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (242.308	+	255.751)	/	2 )	/	563.68	*	365 / 4
=	249.0295					/	563.68	*	365 / 4
=	40.31

United Therapeutics (FRA:UTH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

United Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

United Therapeutics (FRA:UTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » United Therapeutics Corp (FRA:UTH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

UTHR:USA UTH:Germany

Address

1040 Spring Street, Silver Spring, MD, USA, 20910

Website

https://www.unither.com

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

United Therapeutics (FRA:UTH) Headlines

No Headlines